Search Results - "Dean, O.M."

Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors by Berk, M., Kapczinski, F., Andreazza, A.C., Dean, O.M., Giorlando, F., Maes, M., Yücel, M., Gama, C.S., Dodd, S., Dean, B., Magalhães, P.V.S., Amminger, P., McGorry, P., Malhi, G.S.

“…▶ Bipolar disorder is associated with an active process of neuroprogression. ▶ Oxidative, inflammatory and neurotrophic factors play a role in the process. ▶…”
Get full text

N -acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial by Magalhães, P.V, Dean, O.M, Bush, A.I, Copolov, D.L, Malhi, G.S, Kohlmann, K, Jeavons, S, Schapkaitz, I, Anderson-Hunt, M, Berk, M

“…Abstract Background The evidence base for the pharmacological treatment of bipolar II disorder is limited. In bipolar disorder, there is evidence for…”
Get full text

C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications by Fernandes, B S, Steiner, J, Bernstein, H-G, Dodd, S, Pasco, J A, Dean, O M, Nardin, P, Gonçalves, C-A, Berk, M

“…The inflammatory hypothesis of schizophrenia (SZ) posits that inflammatory processes and neural–immune interactions are involved in its pathogenesis, and may…”
Get full text

Patient centric measures for a patient centric era: Agreement and convergent between ratings on The Patient Global Impression of Improvement (PGI-I) scale and the Clinical Global Impressions – Improvement (CGI-S) scale in bipolar and major depressive disorder by Mohebbi, M., Dodd, S., Dean, O.M., Berk, M.

“…Concordant with an increased emphasis on consumer engagement, the Patient Global Impression Scale of Improvement (PGI-I) is commonly used as an outcome measure…”
Get full text

Equal remission rates and reduced length of hospital stay with twice-daily repetitive transcranial magnetic stimulation (rTMS) for major depression – A large naturalistic retrospective cohort association study by Barnes, R., Skvarc, D., Fitzgerald, P.B., Berk, M., Dean, O.M., Dodd, S., Schriemer, T., Singh, A.B.

“…Repetitive transcranial magnetic stimulation (rTMS) is a level 1a evidence-based treatment for major depression, but high cost of care and limited…”
Get full text

Evaluation of high dose N- Acetylcysteine on airway inflammation and quality of life outcomes in adults with bronchiectasis: A randomised placebo-controlled pilot study by Jayaram, L., King, P.T., Hunt, J., Lim, M., Park, C., Hu, E., Dousha, L., Ha, P., Bartlett, J.B., Southcott, A.M., Muruganandan, S., Vogrin, S., Rees, M.A., Dean, O.M., Wong, C.A.

“…High dose N acetylcysteine (NAC), a mucolytic, anti-inflammatory and antioxidant agent has been shown to significantly reduce exacerbations, and improve…”
Get full text

Diet quality, dietary inflammatory index and body composition as predictors of N-acetylcysteine and mitochondrial agents efficacy in bipolar disorder by Ashton, M., Dean, O.M., Marx, W., Mohebi, M., Berk, M., Malhi, G.S., Ng, C., Cotton, S.M., Dodd, S., Sarris, J., Hopwood, M., Voigt, C., Faye-Chauhan, K., Kim, Y., Dash, S.R., Jacka, F.N., Shivappa, N., Hebert, J., Turner, A.

Get full text

Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder by Magalhães, P.V., Dean, O.M., Bush, A.I., Copolov, D.L., Weisinger, D., Malhi, G.S., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Berk, M.

“…Bipolar disorder (BD) is intricately associated with chronic clinical conditions. Medical comorbidity is not only more prevalent in mood disorders, but is…”
Get full text